Cytokine & Growth Factor Reviews

Papers
(The TQCC of Cytokine & Growth Factor Reviews is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy120
Endothelial and macrophage interactions in the angiogenic niche106
Roles of the gut microbiota in severe SARS-CoV-2 infection103
Multifaceted role of CD14 in innate immunity and tissue homeostasis99
MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets92
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?86
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs76
Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis74
Development of mRNA vaccines against respiratory syncytial virus (RSV)65
Galectins as modulators of receptor tyrosine kinases signaling in health and disease60
The anti-inflammatory effects of itaconate and its derivatives in neurological disorders59
The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases55
Editorial Board55
Editorial Board55
Editorial Board54
ORF8a as a viroporin in SARS-CoV-2 infection?54
Editorial Board54
The conundrum of current anti-SARS-CoV-2 vaccines53
Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders51
Response to: Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcom50
Serum amyloid A and inflammasome activation: A link to breast cancer progression?47
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon46
Cytokine signalling in formation of neutrophil extracellular traps: Implications for health and diseases45
LC3B: A microtubule-associated protein influences disease progression and prognosis44
Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics43
Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism43
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases42
Influence of adipose tissue immune dysfunction on childhood obesity42
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling40
Neurotrophic factors and their receptors in lung development and implications in lung diseases40
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis39
T cell receptor signaling in the differentiation and plasticity of CD4+ T cells38
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells38
Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment36
MDSCs might be “Achilles heel” for eradicating CSCs35
Unveiling cytokine charge disparity as a potential mechanism for immune regulation34
Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways33
Crosstalk between glucose metabolism, lactate production and immune response modulation32
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions32
Role of circular RNA in myocardial ischemia and ageing-related diseases31
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?31
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia31
The cytokine interleukin-11 crucially links bone formation, remodeling and resorption30
FGF/FGFR signaling: From lung development to respiratory diseases30
Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic30
Harnessing the potential of CD40 agonism in cancer therapy28
GLP-1R agonist therapy and vaccine response: Neglected implications27
COVID-19: From emerging variants to vaccination26
Exosomes as a modulator of immune resistance in human cancers26
The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis26
The role of transforming growth factor β in cervical carcinogenesis25
The Immunopathogenesis of a Cytokine Storm: The Key Mechanisms Underlying Severe COVID-1925
Impact of chronic stress on intestinal mucosal immunity in colorectal cancer progression25
Apoptotic cell-derived metabolites in efferocytosis-mediated resolution of inflammation24
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies23
Role of the APRIL molecule in solid tumors23
Pharmacological therapies and drug development targeting SARS-CoV-2 infection23
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy22
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-1922
A quartet of cancer stem cell niches in hepatocellular carcinoma21
Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing21
Targeting NKG2D/NKG2DL axis in multiple myeloma therapy21
NLRP1 inflammasome in neurodegenerative disorders: From pathology to therapies21
Editorial Board20
Interleukin-26 in host defense and inflammatory disorders of the airways20
Editorial Board20
Editorial Board19
Editorial Board19
0.066496849060059